Integrum says OPRA implant study in Ukrainian war veterans shows 97.9% survival at 1 year after S2
Integrum flagged a newly published clinical study on its OPRA implant system in Ukrainian war veterans with combat-related amputations. Results were presented as published findings, not a future conference readout. Study outcomes pointed to strong short-term implant durability with no mechanical failures reported, despite complex battlefield injuries. Safety profile showed post-surgery infections in some patients, aligning with prior experience in similar clinical settings. Publication supports Integrum’s push in Ukraine, where bone-anchored prostheses are moving into a state-funded pilot program. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Integrum AB published the original content used to generate this news brief on October 14, 2026, and is solely responsible for the information contained therein. (C)
Integrum flagged a newly published clinical study on its OPRA implant system in Ukrainian war veterans with combat-related amputations. Results were presented as published findings, not a future conference readout. Study outcomes pointed to strong short-term implant durability with no mechanical failures reported, despite complex battlefield injuries. Safety profile showed post-surgery infections in some patients, aligning with prior experience in similar clinical settings.
Publication supports Integrum’s push in Ukraine, where bone-anchored prostheses are moving into a state-funded pilot program. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Integrum AB published the original content used to generate this news brief on October 14, 2026, and is solely responsible for the information contained therein.
(C)